Background: The mechanisms of Meniere's disease (MD) remain largely unknown. The purpose of this study was to identify possible genetic variants associated with immune regulation in MD.

Methods: The whole immune genome of 16 Chinese patients diagnosed with sporadic MD was sequenced using next-generation sequencing.

Results: Definite pathological variants of (c.1223G>A, c.1105C>T), (c.5287C>T), and (c.445C>T) contributing to the clinical phenotype were found in three patients. Limited and likely pathological variants of (c.2228G>A) and (c.560G>A) were detected in one patient each. The following definite pathological variants impairing the structure and function of translated proteins were detected in 10 patients, and multigene variants occurred in five patients: (>), (c.1228A>C), (c.169C>T), (c.200G>C), (c.1937G>T), (c.2533G>A), (c.11498A>G), (c.788A>G), (c.470G>A), (c.11972A>T), (c.226G>A), (c.4613A>G), (c.2228G>A), (c.445C>T), (c.151G>A), and (c.2470G>A). The following limited pathological variants impairing the structure and function of translated proteins were detected in five patients, with double gene variants identified in one patient: (c.1396G>A), (c.2057G>A), (c.2039T>C), (c.1814C>T), (c.4049T>C), and (c.734G>A).

Conclusion: Patients with sporadic MD carry multiple genetic variants involved in multiple steps of immune regulation, which might render patients susceptible to developing inflammation via both autoimmune and autoinflammation mechanisms upon internal stress.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232973PMC
http://dx.doi.org/10.3389/fneur.2023.1159658DOI Listing

Publication Analysis

Top Keywords

pathological variants
16
genetic variants
12
variants
9
multiple genetic
8
variants involved
8
patients
8
chinese patients
8
patients sporadic
8
meniere's disease
8
immune regulation
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!